Bath & Body Works (NYSE:BBWI) Announces Quarterly Earnings Results

Bath & Body Works (NYSE:BBWI) posted its earnings results on Thursday. The company reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.04 by $0.05, Zacks reports. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. Bath & Body Works updated its Q1 2025 guidance to 0.360-0.430 EPS and its FY 2025 guidance to 3.250-3.600 EPS.

Bath & Body Works Stock Performance

Shares of BBWI stock traded down $5.14 during trading hours on Thursday, reaching $35.95. The company had a trading volume of 11,074,102 shares, compared to its average volume of 3,684,232. The business has a fifty day moving average price of $37.82 and a 200-day moving average price of $34.07. Bath & Body Works has a one year low of $26.20 and a one year high of $52.99. The firm has a market cap of $7.79 billion, a PE ratio of 8.77, a price-to-earnings-growth ratio of 0.92 and a beta of 1.83.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 21st will be issued a $0.20 dividend. The ex-dividend date is Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.23%. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.51%.

Analysts Set New Price Targets

BBWI has been the topic of a number of research analyst reports. Morgan Stanley decreased their price target on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a report on Thursday, November 21st. Barclays raised shares of Bath & Body Works from an “underweight” rating to an “equal weight” rating and raised their price target for the stock from $34.00 to $43.00 in a report on Monday. Deutsche Bank Aktiengesellschaft raised their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. TD Cowen raised their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a report on Thursday, December 12th. Finally, Piper Sandler raised their price target on shares of Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a report on Monday, January 6th. Six investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, Bath & Body Works presently has an average rating of “Moderate Buy” and an average price target of $44.44.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.